biotech

Bio-Analyst

Research Platform
person
Tier-BPublic-ready6/27/2026

Probiotics

Glucose and metabolic health markers is closer to a research marker, so it should be read separately from a directly felt benefit.

Human evidence exists, but it is mostly in patient or disease contexts, so the score is handled conservatively.

Representative tier calculated from paper evidence that passed the collection audit.

Papers analyzed
89
Caution signal
Low
Representative score
74.4
Glucose and metabolic health markersStress Response and Sleep ChangesCognition, memory, and focus

Main benefit evidence

The representative ingredient tier is calculated from these target-level evidence groups.

Glucose and metabolic health
6 studiesTier-B
Glucose and metabolic health markers
Fairly consistent positive signal in studiesResearch marker focusPatient-group study

This card is closer to a measured biomarker or lab outcome than a directly felt user benefit. These findings come from a defined study population, so everyday effects may differ.

Evidence score
58.5
Study context
Patient-group study

This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.

Stress and mood
6 studiesTier-B
Stress Response and Sleep Changes
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study

These findings come from stress response, cortisol, anxiety, or sleep outcomes. They may mix felt benefits with physiological markers.

Evidence score
58.5
Study context
Patient-group study

This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.

Cognition and focus
4 studiesTier-B
Cognition, memory, and focus
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study

Potential benefit studied in Cognition and focus. These findings come from a defined study population, so everyday effects may differ.

Evidence score
54.6
Study context
Patient-group study

This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.

Blood lipids
4 studiesTier-B
Cholesterol and triglycerides
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study

Potential benefit studied in Blood lipids. These findings come from a defined study population, so everyday effects may differ.

Evidence score
54.6
Study context
Patient-group study

This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.

Immune and respiratory health
4 studiesTier-B
Immune and respiratory support
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study

Potential benefit studied in Immune and respiratory health. These findings come from a defined study population, so everyday effects may differ.

Evidence score
54.6
Study context
Patient-group study

This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.

Digestion and gut health
4 studiesTier-C
Digestion and gut comfort
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study

Potential benefit studied in Digestion and gut health. These findings come from a defined study population, so everyday effects may differ.

Evidence score
48.6
Study context
Patient-group study

This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.

Recent research

Updated This Month10 new papers

Key cautions to review

Standalone side-effect signals and combination cautions are listed separately.

Caution index
0.8
Caution band: Low
Caution signals
1
Side effects + combos + curated rules
Key precautions
No curated contraindication rule is available yet, but literature caution signals are shown below.
Standalone side effects, combination cautions, and positive combos are separated below.

Standalone side effects

Adverse effect signal1 papers
Reported adverse effects including Lactobacillus sepsis and D-lactic acidosis in children with short bowel syndrome supplemented with probiotics.human · unknown

Evidence summaries

Paper IDs and full lists are private. Only study types and summaries are shown.

Key Evidence #1
Public scholarly dataCitation signal: 812
observational

It is demonstrated that probiotic consumption for 12 weeks positively affects cognitive function and some metabolic statuses in the AD patients and no considerable effect on other biomarkers of oxidative stress and inflammation, fasting plasma glucose, and oth

Key Evidence #2
Public scholarly dataCitation signal: 779
review

This study aims to underline the possible beneficial impact of probiotics for human health and medical sectors and for better lifestyle.

Key Evidence #3
Public scholarly dataCitation signal: 737
observational

In conclusion, probiotic treatment PFW displayed a growth-promoting effect that was comparable to avilamycin treatment, and modulated the composition and, to an extent, the activities of the cecal microflora, resulting in a significant probiotic effect.

3 more summariesLimited representative sample by study type.
>
Public scholarly dataCitation signal: 641
observational

Results provide the first evidence that the intake of probiotics may help reduce negative thoughts associated with sad mood, as well as a potential preventive strategy for depression.

Public scholarly dataCitation signal: 285
observational

This study found no evidence that the probiotic formulation is effective in treating low mood, or in moderating the levels of inflammatory and other biomarkers.

Public scholarly dataCitation signal: 249
review

The purpose of this review article is to provide the most comprehensive and updated review on the utility of prebiotics, probiotics, and synbiotics in the management of active Crohn’s disease and ulcerative colitis/pouchitis.

Probiotics
arrow_backBack to list